Disruption of Diacylglycerol Kinase Delta (DGKD) Associated with Seizures in Humans and Mice

Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
The American Journal of Human Genetics (Impact Factor: 10.99). 05/2007; 80(4):792-9. DOI: 10.1086/513019
Source: PubMed

ABSTRACT We report a female patient with a de novo balanced translocation, 46,X,t(X;2)(p11.2;q37)dn, who exhibits seizures, capillary abnormality, developmental delay, infantile hypotonia, and obesity. The 2q37 breakpoint observed in association with the seizure phenotype is of particular interest, because it lies near loci implicated in epilepsy in humans and mice. Fluorescence in situ hybridization mapping of the translocation breakpoints showed that no known genes are disrupted at Xp11.2, whereas diacylglycerol kinase delta (DGKD) is disrupted at 2q37. Expression studies in Drosophila and mouse suggest that DGKD is involved in central nervous system development and function. Electroencephalographic assessment of Dgkd mutant mice revealed abnormal epileptic discharges and electrographic seizures in three of six homozygotes. These findings implicate DGKD disruption by the t(X;2)(p11.2;q37)dn in the observed phenotype and support a more general role for DGKD in the etiology of seizures.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The functions of type II diacylglycerol kinase (DGK) and - in the brain are still unclear. As a first step, we investigated the spatial and temporal expression of DGK and - in the brains of mice. DGK2, but not DGK1, was highly expressed in layers II-VI of the cerebral cortex; CA-CA3 regions and dentate gyrus of hippocampus; mitral cell, glomerular and granule cell layers of the olfactory bulb; and the granule cell layer in the cerebellum in 1- to 32-week-old mice. DGK2 was expressed just after birth, and its expression levels dramatically increased from weeks 1 to 4. A substantial amount of DGK (1/2) was detected in layers II-VI of the cerebral cortex, CA1 and CA2 regions and dentate gyrus of the hippocampus, mitral cell and glomerular layers of the olfactory bulb, and Purkinje cells in the cerebellum of 1- to 32-week-old mice. DGK2 expression reached maximum levels at P5 and decreased by 4 weeks, whereas DGK1 increased over the same time frame. These results indicate that the expression patterns of DGK isozymes differ from each other and also from other isozymes, and this suggests that DGK and - play distinct and specific roles in the brain.
    Acta histochemica et cytochemica official journal of the Japan Society of Histochemistry and Cytochemistry 10/2014; 63(1). DOI:10.1369/0022155414559130 · 1.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The two-pore domain potassium (K2P) channels TASK-1 (KCNK3) and TASK-3 (KCNK9) are important determinants of background K(+) conductance and membrane potential. TASK-1/3 activity is regulated by hormones and transmitters that act through G protein-coupled receptors (GPCR) signalling via G proteins of the Galphaq/11 subclass. How the receptors inhibit channel activity has remained unclear. Here, we show that TASK-1 and -3 channels are gated by diacylglycerol (DAG). Receptor-initiated inhibition of TASK required the activity of phospholipase C, but neither depletion of the PLC substrate PI(4,5)P2 nor release of the downstream messengers IP3 and Ca(2+). Attenuation of cellular DAG transients by DAG kinase or lipase suppressed receptor-dependent inhibition, showing that the increase in cellular DAG-but not in downstream lipid metabolites-mediates channel inhibition. The findings identify DAG as the signal regulating TASK channels downstream of GPCRs and define a novel role for DAG that directly links cellular DAG dynamics to excitability.
    Nature Communications 11/2014; 5:5540. DOI:10.1038/ncomms6540 · 10.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background We have revealed that the type II diacylglycerol kinases (DGKs) ¿, ¿ and ¿ were expressed in the testis and ovary. However, these enzymes¿ functions in the reproductive organs remain unknown.ResultsIn this study, we first identified the expression sites of type II DGKs in the mouse reproductive organs in detail. Reverse transcription-polymerase chain reaction and Western blotting confirmed that DGK¿2 (splicing variant 2) but not DGK¿1 (splicing variant 1) and DGK¿ were expressed in the testis, ovary and uterus. DGK¿1 (splicing variant 1) but not DGK¿2 (splicing variant 2) was strongly detected in the ovary and uterus. Interestingly, we found that a new alternative splicing product of the DGK¿ gene, DGK¿3, which lacks exon 26 encoding 31 amino acid residues, was expressed only in the testis. Moreover, we investigated the distribution of type II DGKs in the testis, ovary and uterus through in situ hybridization. DGK¿2 was distributed in the primary spermatocytes of the testis and ovarian follicles. DGK¿1 was distributed in the oviductal epithelium of the ovary and the luminal epithelium of the uterus. Intriguingly, DGK¿3 was strongly expressed in the secondary spermatocytes and round spermatids of the testis. DGK¿ was distributed in the primary and secondary spermatocyte of the testis.Conclusion These results indicate that the expression patterns of the type II DGK isoforms ¿2, ¿1, ¿3 and ¿ differ from each other, suggesting that these DGK isoforms play specific roles in distinct compartments and developmental stages of the reproductive organs, especially in the processes of spermatogenesis and oocyte maturation.
    BMC Developmental Biology 01/2015; 15(1):6. DOI:10.1186/s12861-015-0055-z · 2.75 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014